EMA Withdrawn: Monotard (Insulin human) — Novo Nordisk A/S

View source ↗

Summary

The EMA indicates Monotard (insulin human) has been withdrawn from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Monotard (insulin human)

Snippet

Status: Withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 25/04/2002